Joo Young Jung Selected Research

Joo Young Jung Research Topics

Disease

8	Neoplasms (Cancer) 02/2024 - 12/2003
7	Stomach Neoplasms (Stomach Cancer) 02/2024 - 01/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2010 - 10/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2011
2	Hypersensitivity (Allergy) 01/2022 - 06/2017
2	Anemia 06/2021 - 10/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2013
2	Thrombocytopenia (Thrombopenia) 06/2017 - 01/2015
2	Neutropenia 01/2015 - 10/2013
2	Pain (Aches) 04/2013 - 09/2010
2	Cancer Pain 04/2013 - 09/2010
2	Disease Progression 10/2010 - 03/2009
1	Weight Loss (Weight Reduction) 02/2024
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Hypoalbuminemia 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2016
1	Adenocarcinoma 04/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2015
1	Injection Site Reaction 01/2014
1	Multiple Myeloma 01/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2014
1	Nausea 09/2013
1	Vomiting 09/2013
1	Breakthrough Pain 09/2010
1	Cholangiocarcinoma 09/2010
1	Drug-Related Side Effects and Adverse Reactions 04/2009
1	Subdural Hematoma (Subdural Hemorrhage) 04/2009
1	Brain Neoplasms (Brain Tumor) 03/2009
1	Infections 03/2005
1	Meningeal Carcinomatosis 12/2003
1	Airway Obstruction (Choking) 03/2003
1	Anus Neoplasms (Anal Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

6	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2016 - 10/2009
5	Docetaxel (Taxotere)FDA Link 04/2016 - 02/2009
5	Cisplatin (Platino)FDA LinkGeneric 09/2013 - 01/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 11/2011
3	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 01/2003
3	Gemcitabine FDA Link 04/2015 - 10/2006
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 02/2009
2	PlatinumIBA 01/2022 - 10/2010
2	S 1 (combination)IBA 04/2016 - 04/2015
2	Leucovorin (Folinic Acid)FDA Link 01/2016 - 02/2009
1	AlbuminsIBA 02/2024
1	RamucirumabIBA 02/2024
1	SodiumIBA 02/2024
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	AntigensIBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 06/2021
1	Hormones (Hormone)IBA 01/2021
1	Inosine Triphosphate (ITP)IBA 06/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2017
1	Dapsone FDA Link 06/2017
1	XELOXIBA 01/2015
1	Capecitabine (Xeloda)FDA Link 01/2015
1	Bortezomib (Velcade)FDA Link 01/2014
1	ramosetron (Nasea)IBA 09/2013
1	Aprepitant (Emend)FDA Link 09/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2013
1	Serotonin AntagonistsIBA 09/2013
1	SteroidsIBA 09/2013
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2011
1	Pemetrexed (MTA)FDA Link 10/2010
1	Carboplatin (JM8)FDA LinkGeneric 10/2010
1	Fentanyl (Sublimaze)FDA LinkGeneric 09/2010
1	Antidepressive Agents (Antidepressants)IBA 09/2010
1	Analgesics (Analgesic Drugs)IBA 09/2010
1	Opioid Analgesics (Opioids)IBA 09/2010
1	Gefitinib (Iressa)FDA Link 04/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2009
1	ErbB Receptors (EGF Receptor)IBA 04/2009
1	Coloring Agents (Dyes)IBA 01/2006
1	belotecanIBA 01/2006
1	Immunoglobulin M (IgM)IBA 03/2005
1	Viral DNAIBA 03/2005
1	AntibodiesIBA 03/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2003
1	Methotrexate (Mexate)FDA LinkGeneric 12/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2003
1	Drug CombinationsIBA 12/2003
1	OzoneIBA 03/2003

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 02/2024 - 12/2003
6	Therapeutics 01/2022 - 12/2003
3	Combination Drug Therapy (Combination Chemotherapy) 10/2013 - 02/2009
1	Castration 01/2021
1	Intravenous Administration 01/2014
1	Pain Management 04/2013
1	Salvage Therapy 10/2010
1	Cranial Irradiation 03/2009
1	TP protocol 02/2009
1	Induction Chemotherapy 01/2003
1	Radiotherapy 01/2003